Development of curative therapies for sickle cell disease

Recent advances in managing Sickle Cell Disease (SCD) significantly improved patient survival and quality of life. Disease-modifying drug therapies such as hydroxyurea, L-glutamine, voxelotor, and crizanlizumab reduce pain crises and severe complications. Allogeneic hematopoietic stem cell transplan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanhehco, Yvette C., Nathu, Ghazala, Vasovic, Ljiljana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729691/
https://www.ncbi.nlm.nih.gov/pubmed/36507504
http://dx.doi.org/10.3389/fmed.2022.1055540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729691/
https://www.ncbi.nlm.nih.gov/pubmed/36507504
http://dx.doi.org/10.3389/fmed.2022.1055540

Ejemplares similares